Literature DB >> 11851940

Transfusion practice in Helsinki University Central Hospital: an analysis of diagnosis-related groups (DRG).

M T Syrjälä1, I Kytöniemi, K Mikkolainen, J Ranimo, J Lauharanta.   

Abstract

Transfusion data combined with data automatically recorded in hospital databases provides an outstanding tool for blood utilization reporting. When the reporting is performed with an online analytical processing (OLAP) tool, real time reporting can be provided to blood subscribers. When this data is combined with a common patient classification system, Diagnosis-Related Groups (DRG), it is possible to produce statistical results, that are similar in different institutions and may provide a means for international transfusion bench-marking and cost comparison. We use a DRG classification to describe the transfusion practice in Helsinki University Central Hospital. The key indicators include the percentage of transfused patients, the number of transfused units and costs in different DRG groups, as well as transfusion rates per DRG weighted treatment episodes. Ninety-three per cent of all transfusions could be classified into different DRGs. The largest blood-using DRG group was acute adult leukaemia (DRG 473), which accounted for 10.4% of all transfusion costs. The 13 largest blood consuming DRGs accounted for half the total costs in 1998. Currently, there is a lack of an internationally accepted standardized way to report institutional or national transfusion practices. DRG-based transfusion reporting might serve as a means for transfusion benchmarking and thus aid studies of variations in transfusion practice.

Entities:  

Mesh:

Year:  2001        PMID: 11851940     DOI: 10.1046/j.1365-3148.2001.00338.x

Source DB:  PubMed          Journal:  Transfus Med        ISSN: 0958-7578            Impact factor:   2.019


  5 in total

1.  Blood transfusion utilization and recipient survival at Hospital das Clinicas in São Paulo, Brazil.

Authors:  Thelma T Goncalez; Ester C Sabino; Ligia Capuani; Jing Liu; David J Wright; Judy H Walsh; Joao E Ferreira; Dalton A Chamone; Michael P Busch; Brian Custer
Journal:  Transfusion       Date:  2012-04       Impact factor: 3.157

2.  Blood component use and associated costs after standard dose chemotherapy--a prospective analysis of routine hospital care in lymphoproliferative disorders and NSCLC in Germany.

Authors:  Bernadette Paessens; Angela Ihbe-Heffinger; Christoph von Schilling; Rita Shlaen; Rudolf Bernard; Christian Peschel; Wolfgang Schramm; Karin Berger
Journal:  Support Care Cancer       Date:  2011-05-12       Impact factor: 3.603

3.  DRGs in Transfusion Medicine and Hemotherapy in Germany.

Authors:  Matthäus Bauer; Helmut Ostermann
Journal:  Transfus Med Hemother       Date:  2012-03-08       Impact factor: 3.747

4.  Retrospective Analysis of the Blood Component Utilization in a University Hospital of Maximum Medical Care.

Authors:  R Georg Geißler; Dominik Franz; Hubert Buddendick; Petra Krakowitzky; Holger Bunzemeier; Norbert Roeder; Hugo Van Aken; Torsten Kessler; Wolfgang Berdel; Walter Sibrowski; Peter Schlenke
Journal:  Transfus Med Hemother       Date:  2012-03-22       Impact factor: 3.747

5.  Comparative analysis and influencing factors of hospitalization expenses of three single diseases in a tertiary Class A general hospital.

Authors:  Chenyu Wang; Xi Chen; Liming Pan; Hao Lin; Xiaoling Shang; Guogang Xu; Xiantao Huang
Journal:  Am J Transl Res       Date:  2022-04-15       Impact factor: 3.940

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.